Related Experiment Videos
Insights
Current growth hormone (GH) deficiency diagnostic criteria miss some children who benefit from GH therapy. A trial of GH treatment with monitoring is key to identifying these patients for optimal growth.
Area of Science:
- Pediatric Endocrinology
- Growth and Development
- Hormone Therapy
Background:
- Established criteria for diagnosing growth hormone (GH) deficiency are insufficient to identify all children who could benefit from GH therapy.
- A spectrum of GH secretion exists in short, slow-growing children, with some having inadequate secretion for optimal height growth.
- Accurate assessment requires expertise in pediatric diseases, growth patterns, and endocrinology.
Purpose of the Study:
- To highlight the limitations of current diagnostic criteria for GH deficiency in children.
- To emphasize the need for alternative diagnostic approaches for identifying children who will respond to GH therapy.
- To underscore the role of a diagnostic/therapeutic trial in managing short stature.
Main Methods:
- Utilizing auxological monitoring during a diagnostic/therapeutic trial of GH therapy.
- Evaluating growth patterns and response to treatment in short, slow-growing children.
- Clinical assessment integrating knowledge of pediatric diseases and endocrinology.
Main Results:
- Existing diagnostic standards fail to identify all children responsive to GH therapy.
- A trial of GH therapy is often necessary to reveal potential benefits in select patients.
- Auxological monitoring is crucial for assessing treatment efficacy.
Conclusions:
- A growth hormone (GH) therapy trial is essential for diagnosing GH deficiency in some short children.
- Current diagnostic criteria are inadequate for identifying all children who benefit from GH treatment.
- Specialized knowledge in pediatric endocrinology is vital for managing short stature with GH therapy.
Abstract:
Existing criteria for the diagnosis of growth hormone (GH) deficiency do not identify all children who can be made to grow faster with GH. There is a spectrum of GH secretion in short slowly growing normal children and in some cases the secretion may be inadequate to promote optimum growth in height. A diagnostic/therapeutic trial of GH therapy, with auxological monitoring, may be the only means of identifying some patients who will benefit. Assessment of the place for GH therapy in the treatment of short stature requires special knowledge of childhood diseases, growth, and endocrinology.